CAS: 1377239-83-2
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-1-piperazinyl]-8-nitro-6-(trifluoromethyl)- REF: IN-DA0013RRCAS: 1377239-83-2 | 97% | 95,00 €~478,00 € | Mar 07 Ene 25 | |
Macozinone REF: TM-T3583CAS: 1377239-83-2 | 100% - 99.5% | 36,00 €~1.190,00 € | Mar 14 Ene 25 | |
PBTZ169 REF: 3D-CFC23983CAS: 1377239-83-2 | Min. 95% | A consultar | Mar 18 Feb 25 |
4H-1,3-Benzothiazin-4-one, 2-[4-(cyclohexylmethyl)-1-piperazinyl]-8-nitro-6-(trifluoromethyl)-
CAS:1377239-83-2
Fórmula:
C20H23F3N4O3S
Pureza:
97%
Forma y color:
Solid
Peso molecular:
456.4818
Ref: IN-DA0013RR
5mg | 95,00 € | ||
10mg | 107,00 € | ||
25mg | 165,00 € | ||
50mg | 189,00 € | ||
100mg | 299,00 € | ||
250mg | 478,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Macozinone
CAS:1377239-83-2
Macozinone (PBTZ169) inhibits decaprenylphosphoryl-β-d-ribose 2′-oxidase (DprE1), more efficiently than BTZ043.
Fórmula:
C20H23F3N4O3S
Pureza:
100% - 99.5%
Forma y color:
Solid
Peso molecular:
456.48
Ref: TM-T3583
1mg | 36,00 € | ||
5mg | 79,00 € | ||
10mg | 109,00 € | ||
25mg | 212,00 € | ||
50mg | 346,00 € | ||
100mg | 576,00 € | ||
200mg | 808,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
PBTZ169
CAS:1377239-83-2
PBTZ169 is a new drug that is being developed for the treatment of tuberculosis. It …
Fórmula:
C20H23F3N4O3S
Pureza:
Min. 95%
Peso molecular:
456.48 g/mol
Ref: 3D-CFC23983
10mg | 271,00 € | ||
100mg | 1.015,00 € |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025